Literature DB >> 10646899

Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific.

A Giannoudis1, M F Evans, S A Southern, C S Herrington.   

Abstract

Human papillomavirus (HPV) infection appears to be an early event in cervical carcinogenesis with additional abnormalities being required for biological transformation. We have analysed 179 low-grade cervical squamous intra-epithelial lesions (SILs) and 15 normal cervices for the presence of HPV using both in situ hybridization and polymerase chain reaction (PCR). PCR was performed with GP5+/GP6+ primers followed by hybridization using probes for low (HPV 6, 11, 40, 42, 43, 44), intermediate (HPV 31, 33, 35, 39, 51, 52, 58, 59, 66 and 68) and high-risk HPVs (HPV 16, 18, 45 and 56). Interphase cytogenetic analysis using pericentromeric probes for chromosomes 1, 3, 4, 6, 10, 11, 17, 18 and X was also performed to identify numerical chromosomal abnormalities. Tetrasomy of all nine chromosomes was identified within basal keratinocytes, was restricted to epithelia infected with high risk (17 of 46) or intermediate risk (23 of 83) HPVs but was not HPV type-specific. Tetrasomy was not identified in any of the epithelia infected with low risk HPVs (n = 62). These numbers include multiple infection. These findings indicate that the induction of tetrasomy is a property restricted to high and intermediate-risk HPV types but that it is not type-specific. The factors governing which lesions will develop this abnormality are as yet unclear.

Entities:  

Mesh:

Year:  2000        PMID: 10646899      PMCID: PMC2363287          DOI: 10.1054/bjoc.1999.0937

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene.

Authors:  T Hashida; S Yasumoto
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

2.  Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses.

Authors:  S A Southern; M F Evans; C S Herrington
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

3.  Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality.

Authors:  S Solinas-Toldo; M Dürst; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Cytogenetics of carcinoma of the cervix uteri: a review.

Authors:  N B Atkin
Journal:  Cancer Genet Cytogenet       Date:  1997-05

5.  Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.

Authors:  J T Thomas; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q.

Authors:  R D Steenbergen; J M Walboomers; C J Meijer; E M van der Raaij-Helmer; J N Parker; L T Chow; T R Broker; P J Snijders
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

7.  p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

Authors:  R J Slebos; M H Lee; B S Plunkett; T D Kessis; B O Williams; T Jacks; L Hedrick; M B Kastan; K R Cho
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation.

Authors:  G D Higgins; D M Uzelin; G E Phillips; P McEvoy; R Marin; C J Burrell
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

9.  p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.

Authors:  Z A Stewart; S D Leach; J A Pietenpol
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

View more
  7 in total

1.  Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.

Authors:  Weifang Zhang; Yingwang Liu; Ning Zhao; Hanxiang Chen; Lijun Qiao; Weiming Zhao; Jason J Chen
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  Human papillomavirus in pterygium.

Authors:  M J Gallagher; A Giannoudis; C S Herrington; P Hiscott
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

3.  Chromosomal aberrations accumulate in polyploid cells of high-grade squamous intraepithelial lesions (HSIL).

Authors:  Gábor Méhes; Norbert Speich; Magdolna Bollmann; Reinhard Bollmann
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

4.  Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53.

Authors:  Tamara A Potapova; Christopher W Seidel; Andrew C Box; Giulia Rancati; Rong Li
Journal:  Mol Biol Cell       Date:  2016-08-24       Impact factor: 4.138

Review 5.  The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis.

Authors:  Tamara Potapova; Gary J Gorbsky
Journal:  Biology (Basel)       Date:  2017-02-08

6.  Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation.

Authors:  S A Southern; M H Lewis; C S Herrington
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

7.  Establishment of proliferative tetraploid cells from normal human fibroblasts.

Authors:  Susumu Ohshima; Atsushi Seyama
Journal:  Front Oncol       Date:  2013-08-01       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.